Large-scale testing (Phase 3)Study completedNCT00674362What this trial is testingRheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyWho this might be right forRheumatoid Arthritis UCB Pharma 194
Post-approval studies (Phase 4)Study completedNCT00280644What this trial is testingLeflunomide in Rheumatoid ArthritisWho this might be right forArthritis, Rheumatoid Sanofi 60
Early research (Phase 1)Looking for participantsNCT06946641What this trial is testingA Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsWho this might be right forAtopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA) Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Not applicableActive Not RecruitingNCT07069088What this trial is testingThis Study Aims to Characterize and Compare Patients of Adult-onset RA With Patients of Elderly-onset RA Based on the Clinical Manifestations, Disease Activity, Severity Parameters, and Therapeutic FeaturesWho this might be right forRheumatoid Arthritis (RA) Sohag University 150
Not applicableStudy completedNCT02964156What this trial is testingEffect of a Thin Customized Insole in RAWho this might be right forRheumatoid Arthritis Revmatismesykehuset AS 21
Testing effectiveness (Phase 2)Study completedNCT00520572What this trial is testingA 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis AstraZeneca 385
Testing effectiveness (Phase 2)UnknownNCT03084419What this trial is testingAPRIL (AbatacePt in Rheumatoid Arthritis-ILD)Who this might be right forRheumatoid ArthritisInterstitial Lung Disease Cambridge University Hospitals NHS Foundation Trust 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06293365What this trial is testingTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune DiseaseWho this might be right forSjögrens DiseaseSystemic Lupus ErythematosusRheumatoid Arthritis Novartis Pharmaceuticals 155
Not applicableLooking for participantsNCT07442773What this trial is testingIntervention to Support Partners and Informal Caregivers of Frail RA-patientsWho this might be right forRheumatic Arthritis Glostrup University Hospital, Copenhagen 25
Post-approval studies (Phase 4)Looking for participantsNCT03976245What this trial is testingAdvanced Therapeutics in Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 144
Testing effectiveness (Phase 2)Study completedNCT00074438What this trial is testingStudy to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Genentech, Inc. 465
Post-approval studies (Phase 4)Study completedNCT01548768What this trial is testingRHYTHM (Formerly Escape II Myocardium)Who this might be right forRheumatoid Arthritis Columbia University 149
Testing effectiveness (Phase 2)Study completedNCT00034060What this trial is testingThe Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With EtanerceptWho this might be right forRheumatoid ArthritisHealthy National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 36
Post-approval studies (Phase 4)Ended earlyNCT00706797What this trial is testingStudy Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA SubjectsWho this might be right forRheumatoid Arthritis Wyeth is now a wholly owned subsidiary of Pfizer 141
Testing effectiveness (Phase 2)Study completedNCT01274182What this trial is testingGP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard TherapyWho this might be right forRheumatoid Arthritis Sandoz 312
Large-scale testing (Phase 3)Ended earlyNCT00406419What this trial is testingOcrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)Who this might be right forRheumatoid Arthritis Genentech, Inc. 1,015
Testing effectiveness (Phase 2)Ended earlyNCT00655824What this trial is testingLong-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403Who this might be right forArthritis, Rheumatoid GlaxoSmithKline 124
Not applicableEnded earlyNCT01643863What this trial is testingA Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 1
Testing effectiveness (Phase 2)Study completedNCT01426789What this trial is testingA Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) PatientsWho this might be right forRheumatoid Arthritis Novartis Pharmaceuticals 100
Testing effectiveness (Phase 2)Study completedNCT02093026What this trial is testingExtension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 465